About Us
Our Leadership
Pioneering Leadership Team
Thomas Fuerst, PhD
Executive Chairman
Dr. Fuerst has led the research, development, and manufacturing of biological products for 30+ years.
- Scientific Founder and Research Director at MedImmune; Executive Director R&D, Sanofi; EVP CSO, PharmAthene.
- Director of Vaccines and Biologics in the Office of the Secretary for the U.S. Department of Health and Human Services.
- Director of Biodefense and Emerging Infectious Diseases, vaccines and immunotherapeutic products at BARDA.
- Director for the Advanced Development and Manufacturing Initiative of Biological Countermeasures at DARPA.
- Professor and Director of the Institute for Bioscience and Biotechnology Research for University of Maryland and NIST.
Armand Girard, MBA
Board Advisor
Mr. Girard has extensive leadership, strategic planning, clinical development and partnering experience over the past 25 years.
- Chief Business Officer at GlycoMimetics.
- Vice President of Technical Assessment and Sr. Director, Business Development at Shire Pharmaceuticals.
- Established Shire’s Rare Disease and Gene Therapy Business Units through acquisition of Transkaryotic Therapies and licensing deals with Sangamo Biosciences, TiGEM and others.
- Supported Shire’s Strategic Investment Venture Fund—Board observer.
Nathan Lewis, PhD
CTO
Dr. Lewis is an expert in biotechnology with 20+ years of experience in design of cell factories and biologics.
- Led the public efforts to sequence the genomes of the Chinese hamster and diverse CHO cell lines.
- Scientific Coordinator for the CHO cell engineering program at the Novo Nordisk Foundation Center at the Technical University of Denmark.
- Led the development of complex systems biology models and A.I. to study and engineer metabolism, protein secretion, and glycosylation in CHO cells Co-Director of the NNF-funded National Biologics Facility at the Technical University of Denmark.
- Professor of Pediatrics and Bioengineering at the University of California, San Diego.
Bjorn Voldborg, MSc
VP gCHO Cell Manufacturing
Mr. Voldborg is an expert in research, development and production of biologics with over 25 years of experience in the production of recombinant proteins.
- Head of the NNF-funded National Biologics Facility at the Technical University of Denmark (DTU).
- Head of the CHO cell engineering program at the Novo Nordisk Foundation Center for Biosustainability at the DTU.
- Director of the Cell Line and Protein Production facility at the DTU NNF-funded National Biologics Facility.
- Head of the protein production unit at the Center for Protein Research at the University of Copenhagen.
Scientific Advisors
Jeffrey Esko, Ph.D., M.D.
Distinguished Professor of Cellular and Molecular Medicine and Co-Director of the Glycobiology Research and Training Center at the University of California, San Diego.
RESEARCH
Structure, biosynthesis and function of proteoglycans in homeostasis and LSDs
Edward Schuchman, Ph.D.
Professor Genetics and Genomic Sciences and Endowed Chair, Genetic Disease Foundation-Francis Crick Professor at the Ichan School of Medicine at Mount Sinai.
Research
Acid Ceramidase, Lysosomal Storage Diseases, Acid Sphingomyelinase
Vladimir R. Muzykantov, M.D., Ph.D.
Professor and and Vice-Chair of Department Pharmacology of the University of Pennsylvania Perelman School of Medicine.
RESEARCH
Targeting of drugs to develop strategies for controlled site-specific delivery to defined tissues and organs
George Rodgers, M.D., Ph.D.
Professor of Medicine in the Division of Hematology and Hematologic Malignancies at the University of Utah School of Medicine.
RESEARCH
Classical hematology expert for hemophilia and thrombosis
Prof. Noel G McElvaney
Head of the Department of Medicine and Respiratory Research Division, at Beaumont Hospital, Dublin, Royal College of Surgeons in Ireland (RCSI).
RESEARCH
Cystic fibrosis (CF), alpha-1 antitrypsin deficiency (AATD), infection, immunity, and rare lung diseases
Learn More
Learn more about NeuImmune by downloading our most recent corporate presentation